GLP-1 medications like Ozempic, Wegovy, Zepbound, and Mounjaro are being hailed as breakthrough treatments, reshaping how Americans think about managing weight and metabolic health
Levering var hurtig og emballagen var pn og professionel
Semaglutide is a once-weekly GLP-1 injection
A popular dual agonist, tirzepatide (Mounjaro), activates both GLP-1R and GIPR, producing synergistic effects on insulin secretion, appetite suppression, and weight reduction (Table 1)
[DOI] [PubMed] [Google Scholar] 10.Chiasson J.L., Josse R.G., Gomis R., Hanefeld M., Karasik A., Laakso M., STOP-NIDDM Trial Research Group Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: The STOP-NIDDM trial
The science is still very thin